Sarah Bétrian

Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults

M.L. Piel-Julian, Matthieu Mahévas, Johanne Germain et al. · Journal of Thrombosis and Haemostasis · 2018 · 132 citations · Full text

Platelet Count Threshold, Immune Thrombocytopenia Adults, Thrombosis +16

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud et al. · Clinical Cancer Research · 2023 · 85 citations · Full text

Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors

Sarah Bétrian, Carlos Gomez‐Roca, Émmanuelle Vigarios et al. · JAMA Dermatology · 2017 · 31 citations

Website Uses Cookies, Ophthalmology, Severe Onycholysis +9

PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study

Alejandra Martínez, Fabrice Lécuru, Nicolò Bizzarri et al. · International Journal of Gynecological Cancer · 2023 · 30 citations · Full text

MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud et al. · Journal of the Endocrine Society · 2021 · 29 citations · Full text

Health Sciences, Dabrafenib Followed, Medicine +15